Page last updated: 2024-09-04

butylscopolammonium bromide and Apnea, Obstructive Sleep

butylscopolammonium bromide has been researched along with Apnea, Obstructive Sleep in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carberry, JC; Eckert, DJ; Grunstein, R; Lim, R; Wellman, A	1

Trials

1 trial(s) available for butylscopolammonium bromide and Apnea, Obstructive Sleep

Article	Year
Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals. Sleep, 2019, 04-01, Volume: 42, Issue:4 Topics: Adult; Airway Resistance; Australia; Butylscopolammonium Bromide; Cross-Over Studies; Double-Blind Method; Electromyography; Female; Humans; Male; Nose; Parasympatholytics; Pharyngeal Muscles; Pharynx; Polysomnography; Pressure; Reboxetine; Respiration; Scopolamine; Sleep; Sleep Apnea, Obstructive; Sleep, REM; Tongue; Wakefulness	2019

Article

Year

Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals.

Sleep, 2019, 04-01, Volume: 42, Issue:4

Topics: Adult; Airway Resistance; Australia; Butylscopolammonium Bromide; Cross-Over Studies; Double-Blind Method; Electromyography; Female; Humans; Male; Nose; Parasympatholytics; Pharyngeal Muscles; Pharynx; Polysomnography; Pressure; Reboxetine; Respiration; Scopolamine; Sleep; Sleep Apnea, Obstructive; Sleep, REM; Tongue; Wakefulness

2019